Clinical trial · Interventional
Testing Two Different Intensities of an Intervention to Enhance REsilience and to Reduce SupportIve Care Needs in Cancer Patients
Testing the Feasibility and Efficacy of Two Different Intensities of an Intervention to Enhance REsilience and to Reduce SupportIve Care Needs in Cancer Patients: A Phase II TriaL
NCT03045003CI-TRIAL-00025886RESILcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this phase II study is to test by feasibility and efficacy of two interprofessional supportive care interventions with different intensities to facilitate resilience in patients and thereby to reduce their unmet supportive care needs.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Solid Tumor, Adult | Adult Solid Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| RESIL Intervention | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Arm A: Low Intensity
- description
- RESIL Intervention provided by nurses and oncologists of the outpatient oncology unit.
- interventionNames
- Behavioral: RESIL Intervention
- type
- OTHER
- label
- Arm B: High Intensity
- description
- RESIL Intervention provided by nurses and oncologists of the outpatient oncology unit plus 5 nurse-led consultations (3 face-to-face and 2 telephone consultations)
- interventionNames
- Behavioral: RESIL Intervention
Primary outcomes (1)
- measure
- Connor Davidson Resilience Scale Score Change
- timeFrame
Eligibility
Eligibility (as posted)
Show eligibility criteria text
Inclusion Criteria: * age 18 years and older * attending the clinic for the first chemotherapy administration * newly diagnosed (between 4-15 weeks after diagnosis) with a new carcinoma / lymphoma * sufficiently literate in French or German to complete questionnaires. Exclusion Criteria: * recurrent disease * being treated in in-patient or palliative care units * diagnosed with all other cancers * in need of complex chemotherapy * being judged by the oncologist as not being emotionally or physically capable to participate in the trial will be excluded.
References
Publications (0)
Data not yet available
No reference posted for this study.